Melarsoprol

DB12864InvestigationalSmall molecule

Melarsoprol is under investigation in clinical trial NCT00330148 (Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis).

Chemical structure of Melarsoprol
Formula / weight
C12H15AsN6OS2 · 398.33 g/mol (avg)

Resolves to

Compound
UNIIZF3786Q2E8CAS494-79-1ChEMBLCHEMBL166ChEBI6729PubChem10311KEGGC08001
Clinical / RWD
ATCP01CD01
Structure
InChIKeyJCYZMTMYPZHVBF-UHFFFAOYSA-NSMILESNC1=NC(NC2=CC=C(C=C2)[As]2SCC(CO)S2)=NC(N)=N1

What you can answer from here — as of February 21, 2021

1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 7 drug categories
Sign in

Which companies are running trials of Melarsoprol, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In